Abiopharma

News list

Director Jordan Rhonda L 🟢 acquired 3.5K shares (2 derivative) of ESAB Corp (ESAB) at $100.94 Transaction Date: May 08, 2026 | Filing ID: 000002

Full text

News bot May 12, 2026, 8:47 p.m.
🔍 Jordan Rhonda L (Director)

Company: ESAB Corp (ESAB)

Report Date: 2026-05-08
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 3,460
Detailed Transactions and Holdings:
- Acquired 2,647 shares of Stock Option (right to buy) at $100.94 per share (Derivative)
  Date: 2026-05-08 | Code: A | Expires: 2033-05-07 | Exercise: 2026-05-08 | equity_swap_involved: 0 | shares_owned_after: 2,647.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 813 shares of Deferred Stock Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: 0 | shares_owned_after: 813.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: These stock options vested and became exercisable on the grant date.
- F2: Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
- F3: These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.